Multicenter Study on the Efficacy of Transcranial Direct Current Stimulation (tDCS) in Post-stroke Motor Recovery
Primary Purpose
Stroke, Ischemic, Stroke Hemorrhagic
Status
Unknown status
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Anodal transcranial direct current stimulation (A-tDCS)
Cathodal transcranial direct current stimulation (C-tDCS)
Sham stimulation (sham-tDCS)
Neuromotor training
Sponsored by
About this trial
This is an interventional treatment trial for Stroke, Ischemic focused on measuring transcranial direct current stimulation, stroke rehabilitation
Eligibility Criteria
Inclusion Criteria:
- First-ever ischemic stroke
- Red or white stroke
- Barthel Index > 90 before lesion onset
Exclusion Criteria:
- Previous inborn neurological disease
- Previous acquired neurological disease
- Previous or current major psychiatric illness
- Epilepsy or anticonvulsant treatment
- Use of calcium channel blocker drugs
- Treatments with other technologies (robotics, FES, etc.)
- Neurolytic treatments with botulinum toxin
Sites / Locations
- IRCCS Centro San Giovanni di Dio FatebenefratelliRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Sham Comparator
Experimental
Experimental
Arm Label
Control Group
Group 1
Group 2
Arm Description
neuromotor training and placebo stimulation
neuromotor training and cathodal stimulation over the unaffected hemisphere
neuromotor training and anodal stimulation over the affected hemisphere
Outcomes
Primary Outcome Measures
Changes from Baseline Fugl Meyer Assessment Scale (FMA)
Performance-based assessment of sensorimotor impairment
Secondary Outcome Measures
Changes from Baseline Box & Block Test (B&B)
test for manual dexterity of upper extremity function
Changes from Baseline Barthel Index (BI)
measure of daily living activities in relation to personal care and mobility of the patient
Changes from Baseline Trunk Control Test (TCT)
assessment of the deteriorations in trunk control
Changes from Baseline Berg Balance Scale ( BBS)
test of a person's static and dynamic balance abilities
Changes from Baseline 10 Meters Walking Test
evaluation of functional mobility, gait, and vestibular function
Changes from Baseline Functional Ambulatory Classification (FAC)
clinically meaningful outcome measure of mobility
Full Information
NCT ID
NCT04166968
First Posted
November 13, 2019
Last Updated
February 13, 2020
Sponsor
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Collaborators
San Gerardo Hospital, Maggiore Bellaria Hospital, Bologna, Azienda Ospedaliero, Universitaria Pisana, Fondazione Don Carlo Gnocchi Onlus, Azienda Ospedaliera Universitaria Integrata Verona, Azienda Unità Sanitaria Locale di Piacenza, Azienda Ospedaliero Universitaria di Cagliari, Ospedale Policlinico San Martino, I.R.C.C.S. Fondazione Santa Lucia, Catholic University of the Sacred Heart, Istituti Clinici Zucchi, Ospedali Riuniti di Foggia
1. Study Identification
Unique Protocol Identification Number
NCT04166968
Brief Title
Multicenter Study on the Efficacy of Transcranial Direct Current Stimulation (tDCS) in Post-stroke Motor Recovery
Official Title
Multicenter Study on the Efficacy of Transcranial Direct Current Stimulation (tDCS) in Post-stroke Motor Recovery
Study Type
Interventional
2. Study Status
Record Verification Date
February 2020
Overall Recruitment Status
Unknown status
Study Start Date
October 10, 2019 (Actual)
Primary Completion Date
December 2020 (Anticipated)
Study Completion Date
December 2020 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Collaborators
San Gerardo Hospital, Maggiore Bellaria Hospital, Bologna, Azienda Ospedaliero, Universitaria Pisana, Fondazione Don Carlo Gnocchi Onlus, Azienda Ospedaliera Universitaria Integrata Verona, Azienda Unità Sanitaria Locale di Piacenza, Azienda Ospedaliero Universitaria di Cagliari, Ospedale Policlinico San Martino, I.R.C.C.S. Fondazione Santa Lucia, Catholic University of the Sacred Heart, Istituti Clinici Zucchi, Ospedali Riuniti di Foggia
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Several previous studies have used tDCS as a neuromodulation tool, showing improvements in several diseases (Lefaucheur et al., 2017). Based on these observations, it is believed that the use of tDCS in combination with specific motor training may provide the opportunity to induce behavioral improvements in patients with motor deficits. As shown in previous reports brain stimulation can, in fact, interact with the intrinsic ability of the brain to "repair" damaged brain functions, increasing the involvement of compensatory functional networks and thus inducing neuroplasticity. If these low-cost, easy-to-use stimulation techniques prove to be useful in improving motor deficits with long-term effects, the current study would open up new and interesting avenues in the field of neurorehabilitation. Given the potential long-lasting effects of tDCS, there is currently a growing interest in the clinical sector with the aim to reduce motor deficits in patients with brain injury. The most widely used protocols in stroke patients include the application of either anodal on the hypsilesional hemisphere or cathodal tDCS on the unaffected hemisphere (contralateral), so as to increase and decrease the excitability of the motor cortex, respectively (Nitsche and Paulus, 2001).
The main objective of this study is to evaluate the effectiveness of transcranial direct current stimulation in enhancing the functional recovery of the upper limb of stroke patients after three weeks of neuromotor training and subsequent follow-up. The secondary objective is to evaluate the treatment effects on balance, gait, motor dexterity and disability, besides the functional recovery of the lower limb.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke, Ischemic, Stroke Hemorrhagic
Keywords
transcranial direct current stimulation, stroke rehabilitation
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The present study will be conducted in over 15 recruiting centers with a randomized double-blind design. Post-stroke patients will be randomly assigned to 3 parallel groups: Control Group (neuromotor training and sham stimulation), Experimental Group 1 (neuromotor training and cathodal tDCS over the unaffected hemisphere), Group 2 (neuromotor training and anodal tDCS over the affected hemisphere). Participants will be further partitioned on the basis of the acute/subacute and subacute/chronic stages (7-90 and 91 days from lesion onset, respectively).
Masking
ParticipantOutcomes Assessor
Masking Description
Both participants and experimenters will be prevented from having knowledge of the assigned stimulation protocol. To do so, the investigator will create a series of numbers paired with real and sham interventions while the outcome assessor will be aware of the patient-number association only.
Allocation
Randomized
Enrollment
162 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Control Group
Arm Type
Sham Comparator
Arm Description
neuromotor training and placebo stimulation
Arm Title
Group 1
Arm Type
Experimental
Arm Description
neuromotor training and cathodal stimulation over the unaffected hemisphere
Arm Title
Group 2
Arm Type
Experimental
Arm Description
neuromotor training and anodal stimulation over the affected hemisphere
Intervention Type
Device
Intervention Name(s)
Anodal transcranial direct current stimulation (A-tDCS)
Intervention Description
Anodal tDCS will be performed for 20 minutes over the affected hemisphere with an intensity set to 2 mA
Intervention Type
Device
Intervention Name(s)
Cathodal transcranial direct current stimulation (C-tDCS)
Intervention Description
Cathodal tDCS will be performed for 20 minutes over the unaffected hemisphere with an intensity set to 2 mA
Intervention Type
Device
Intervention Name(s)
Sham stimulation (sham-tDCS)
Intervention Description
placebo stimulation
Intervention Type
Behavioral
Intervention Name(s)
Neuromotor training
Intervention Description
conventional neuromotor treatment
Primary Outcome Measure Information:
Title
Changes from Baseline Fugl Meyer Assessment Scale (FMA)
Description
Performance-based assessment of sensorimotor impairment
Time Frame
End of 1st week; End of 2nd week; End of 3rd week; 90 days follow-up
Secondary Outcome Measure Information:
Title
Changes from Baseline Box & Block Test (B&B)
Description
test for manual dexterity of upper extremity function
Time Frame
End of 1st week; End of 2nd week; End of 3rd week; 90 days follow-up
Title
Changes from Baseline Barthel Index (BI)
Description
measure of daily living activities in relation to personal care and mobility of the patient
Time Frame
End of 1st week; End of 2nd week; End of 3rd week; 90 days follow-up
Title
Changes from Baseline Trunk Control Test (TCT)
Description
assessment of the deteriorations in trunk control
Time Frame
End of 1st week; End of 2nd week; End of 3rd week; 90 days follow-up
Title
Changes from Baseline Berg Balance Scale ( BBS)
Description
test of a person's static and dynamic balance abilities
Time Frame
End of 1st week; End of 2nd week; End of 3rd week; 90 days follow-up
Title
Changes from Baseline 10 Meters Walking Test
Description
evaluation of functional mobility, gait, and vestibular function
Time Frame
End of 1st week; End of 2nd week; End of 3rd week; 90 days follow-up
Title
Changes from Baseline Functional Ambulatory Classification (FAC)
Description
clinically meaningful outcome measure of mobility
Time Frame
End of 1st week; End of 2nd week; End of 3rd week; 90 days follow-up
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
First-ever ischemic stroke
Red or white stroke
Barthel Index > 90 before lesion onset
Exclusion Criteria:
Previous inborn neurological disease
Previous acquired neurological disease
Previous or current major psychiatric illness
Epilepsy or anticonvulsant treatment
Use of calcium channel blocker drugs
Treatments with other technologies (robotics, FES, etc.)
Neurolytic treatments with botulinum toxin
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Maria Concetta Pellicciari, PhD
Phone
+39 030 3501597
Email
studioitalianotdcs@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Carlo Miniussi, PhD
Organizational Affiliation
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Official's Role
Principal Investigator
Facility Information:
Facility Name
IRCCS Centro San Giovanni di Dio Fatebenefratelli
City
Brescia
State/Province
Lombardia
ZIP/Postal Code
25125
Country
Italy
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Carlo Miniussi
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Multicenter Study on the Efficacy of Transcranial Direct Current Stimulation (tDCS) in Post-stroke Motor Recovery
We'll reach out to this number within 24 hrs